Cyclerion Therapeutics (CYCN) Revenue (2019 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Revenue of $875000.0 in Q3 2025, up 840.86% quarter-over-quarter from $93000.0 in Q2 2025, and up 351.03% on a YoY basis from $194000.0 in Q3 2024.
Cyclerion Therapeutics (CYCN) Revenue (2019 - 2025) Analysis & Trends
Cyclerion Therapeutics' Revenue history runs 6 years deep, the most recent figure standing at $875000.0 for Q3 2025.
- In Q3 2025, Revenue rose 351.03% year-over-year to $875000.0; the TTM figure through Sep 2025 stood at $2.9 million (up 1371.65% YoY), while the FY2024 annual figure was $2.0 million, changed N/A from the prior year.
- Revenue was $875000.0 for Q3 2025 at Cyclerion Therapeutics, up from $93000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $3.0 million in Q2 2021 to a low of $62000.0 in Q1 2021.
- Historically, Revenue has averaged $728090.9 across 4 years, with a median of $348000.0 in 2021.
- The sharpest annual moves came in 2021 and 2022: Revenue tumbled 93.89% in 2021, then soared 1046.77% in 2022.
- A 4-year view of Revenue shows it stood at $533000.0 in 2021, then slumped by 42.59% to $306000.0 in 2022, then jumped by 490.2% to $1.8 million in 2024, then tumbled by 51.55% to $875000.0 in 2025.
- The last three Revenue figures came in at $875000.0 (Q3 2025), $93000.0 (Q2 2025), and $81000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 875,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Dec 31, 2024 | 1.81 Mn |
| Sep 30, 2024 | 194,000.00 |
| Jun 30, 2022 | 306,000.00 |
| Mar 31, 2022 | 711,000.00 |
| Dec 31, 2021 | 533,000.00 |
| Sep 30, 2021 | 348,000.00 |
| Jun 30, 2021 | 3.00 Mn |
| Mar 31, 2021 | 62,000.00 |
| Dec 31, 2020 | 133,000.00 |
| Sep 30, 2020 | 400,000.00 |
| Jun 30, 2020 | 749,000.00 |
| Mar 31, 2020 | 1.01 Mn |
| Dec 31, 2019 | 1.48 Mn |
| Sep 30, 2019 | 1.40 Mn |
| Jun 30, 2019 | 1.63 Mn |